Published in Neurology on September 01, 1992
Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc Natl Acad Sci U S A (2001) 2.96
Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med (2001) 2.90
Role of microglia in central nervous system infections. Clin Microbiol Rev (2004) 2.69
Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity (2012) 2.56
Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res (2008) 2.40
Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis (2012) 2.37
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A (2002) 2.31
Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J Virol (2001) 2.24
HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J Neuroimmune Pharmacol (2010) 1.87
Whole brain diffusion tensor imaging in HIV-associated cognitive impairment. AJNR Am J Neuroradiol (2004) 1.78
Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets. J Virol (1994) 1.69
Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. Virology (2006) 1.66
Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia. J Virol (2005) 1.65
The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology (2010) 1.64
Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis (2011) 1.59
Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis (2008) 1.56
Abnormalities in resting-state functional connectivity in early human immunodeficiency virus infection. Brain Connect (2011) 1.52
Coordinated regulation of SIV replication and immune responses in the CNS. PLoS One (2009) 1.49
Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection. J Acquir Immune Defic Syndr (2008) 1.46
Transfer of neuropathogenic simian immunodeficiency virus with naturally infected microglia. Am J Pathol (1995) 1.39
Curing HIV: Pharmacologic approaches to target HIV-1 latency. Annu Rev Pharmacol Toxicol (2011) 1.38
Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology (2010) 1.33
Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev (2009) 1.31
The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era. J Neuroimmune Pharmacol (2008) 1.31
Monocyte/macrophages and their role in HIV neuropathogenesis. Immunol Rev (2013) 1.31
Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. J Virol (1998) 1.30
Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes. J Virol (2001) 1.28
Antiretroviral therapy in macrophages: implication for HIV eradication. Antivir Chem Chemother (2009) 1.27
Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest (1993) 1.25
HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PLoS One (2008) 1.23
Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. J Leukoc Biol (2012) 1.22
Loss of neuronal integrity during progressive HIV-1 infection of humanized mice. J Neurosci (2011) 1.22
Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse. Am J Pathol (2009) 1.18
Neuroinvasion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection. J Virol (2007) 1.16
Structural brain alterations can be detected early in HIV infection. Neurology (2012) 1.15
Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy. J Infect Dis (2011) 1.15
HIV-1 latency in monocytes/macrophages. Viruses (2014) 1.13
Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. PLoS One (2014) 1.12
HIV-associated episodic memory impairment: evidence of a possible differential deficit in source memory for complex visual stimuli. J Neuropsychiatry Clin Neurosci (2009) 1.09
Intrinsic Regression Models for Positive-Definite Matrices With Applications to Diffusion Tensor Imaging. J Am Stat Assoc (2009) 1.07
Infection of semen-producing organs by SIV during the acute and chronic stages of the disease. PLoS One (2008) 1.07
Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis. Am J Pathol (2006) 1.06
Correlation of acute humoral response with brain virus burden and survival time in pig-tailed macaques infected with the neurovirulent simian immunodeficiency virus SIVsmmFGb. Am J Pathol (2004) 1.05
Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection. PLoS Pathog (2015) 1.04
Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND). Curr HIV/AIDS Rep (2015) 1.03
Brain creatine elevation and N-Acetylaspartate reduction indicates neuronal dysfunction in the setting of enhanced glial energy metabolism in a macaque model of neuroAIDS. Magn Reson Med (2011) 1.02
Enhancement of human immunodeficiency virus (HIV)-specific CD8+ T cells in cerebrospinal fluid compared to those in blood among antiretroviral therapy-naive HIV-positive subjects. J Virol (2008) 1.02
Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance among HIV-infected patients. Brain Imaging Behav (2010) 1.01
Early physiological abnormalities after simian immunodeficiency virus infection. Proc Natl Acad Sci U S A (1998) 1.01
Acquired immunodeficiency syndrome and the blood-brain barrier. J Neurovirol (2009) 1.00
Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J Leukoc Biol (2006) 0.99
Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res (2006) 0.99
Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis. PLoS One (2013) 0.99
Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations. Brain Pathol (2004) 0.98
Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by luminal microvessel IL-6 and GM-CSF. J Neuroinflammation (2011) 0.98
Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by the p38 mitogen-activated protein kinase pathway. Exp Neurol (2008) 0.98
TRPC channels and their implication in neurological diseases. CNS Neurol Disord Drug Targets (2010) 0.97
Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility. J Virol (2002) 0.97
Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication. Mol Med (2012) 0.96
Anx2 interacts with HIV-1 Gag at phosphatidylinositol (4,5) bisphosphate-containing lipid rafts and increases viral production in 293T cells. PLoS One (2009) 0.96
Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys. Proc Natl Acad Sci U S A (1996) 0.95
Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc Natl Acad Sci U S A (1994) 0.95
Characterization and sociocultural predictors of neuropsychological test performance in HIV+ Hispanic individuals. Cultur Divers Ethnic Minor Psychol (2008) 0.95
Longer ongoing task delay intervals exacerbate prospective memory deficits in HIV-associated neurocognitive disorders (HAND). J Clin Exp Neuropsychol (2012) 0.95
Human immunodeficiency virus type 1 infection of the brain. Clin Microbiol Rev (1993) 0.94
Anti-α4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection. PLoS Pathog (2014) 0.92
Longitudinal analysis of activation markers on monocyte subsets during the development of simian immunodeficiency virus encephalitis. J Neuroimmunol (2006) 0.92
Cerebrospinal fluid is an efficient route for establishing brain infection with feline immunodeficiency virus and transfering infectious virus to the periphery. J Neurovirol (2006) 0.92
Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue. Retrovirology (2012) 0.91
HIV and neurocognitive dysfunction. Curr HIV/AIDS Rep (2013) 0.91
Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS. Curr HIV/AIDS Rep (2015) 0.91
Real-world impact of neurocognitive deficits in acute and early HIV infection. J Neurovirol (2013) 0.90
High frequency of virus-specific CD8+ T cells in the central nervous system of macaques chronically infected with simian immunodeficiency virus SIVmac251. J Virol (2003) 0.90
Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders. Curr HIV Res (2014) 0.89
Efficient transmission and persistence of low-frequency SIVmac251 variants in CD8-depleted rhesus macaques with different neuropathology. J Gen Virol (2012) 0.89
Expression of monocyte markers in HIV-1 infected individuals with or without HIV associated dementia and normal controls in Bangkok Thailand. J Neuroimmunol (2008) 0.89
Evolving character of chronic central nervous system HIV infection. Semin Neurol (2014) 0.89
Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction. Futur HIV Ther (2008) 0.89
Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection. Neurology (2014) 0.88
The cerebrospinal fluid proteome in HIV infection: change associated with disease severity. Clin Proteomics (2012) 0.88
Canonical type I IFN signaling in simian immunodeficiency virus-infected macrophages is disrupted by astrocyte-secreted CCL2. J Immunol (2012) 0.88
Brain alterations within the first 100 days of HIV infection. Ann Clin Transl Neurol (2014) 0.87
Replication of macrophage-tropic and T-cell-tropic strains of human immunodeficiency virus type 1 is augmented by macrophage-endothelial cell contact. J Virol (1995) 0.87
Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND. J Neuroimmune Pharmacol (2013) 0.87
HIV life cycle, innate immunity and autophagy in the central nervous system. Curr Opin HIV AIDS (2014) 0.87
S100β as a novel and accessible indicator for the presence of monocyte-driven encephalitis in AIDS. Neuropathol Appl Neurobiol (2012) 0.87
Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages. J Neuroimmune Pharmacol (2012) 0.87
SIV encephalitis lesions are composed of CD163(+) macrophages present in the central nervous system during early SIV infection and SIV-positive macrophages recruited terminally with AIDS. Am J Pathol (2015) 0.87
Viral diseases of the central nervous system. Curr Opin Virol (2015) 0.87
Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis. Dis Model Mech (2012) 0.86
HIV-1 Nef in macrophage-mediated disease pathogenesis. Int Rev Immunol (2012) 0.86
Angiocentric CD3(+) T-cell infiltrates in human immunodeficiency virus type 1-associated central nervous system disease in children. Clin Diagn Lab Immunol (1999) 0.86
Endothelin-1 and its role in the pathogenesis of infectious diseases. Life Sci (2014) 0.86
Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study. AIDS Res Ther (2011) 0.86
Enhanced PD-1 expression by T cells in cerebrospinal fluid does not reflect functional exhaustion during chronic human immunodeficiency virus type 1 infection. J Virol (2010) 0.86
Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis. Future Virol (2010) 0.86
Reduced genetic diversity in lymphoid and central nervous system tissues and selection-induced tissue-specific compartmentalization of neuropathogenic SIVsmmFGb during acute infection. AIDS Res Hum Retroviruses (2009) 0.85
Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation. J Neuroimmune Pharmacol (2010) 0.85
Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 8.45
Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J (2001) 4.93
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA (1999) 4.71
Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med (1999) 3.98
Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol (1997) 3.38
Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax (2007) 3.34
Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet (1988) 3.21
Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation. Nature (1986) 2.49
The x gene is essential for HTLV replication. Science (1985) 2.44
Diagnostic and therapeutic considerations in Nocardia asteroides infection. Medicine (Baltimore) (1974) 2.42
Bacteriologic diagnosis of acute pneumonia. Comparison of sputum, transtracheal aspirates, and lung aspirates. JAMA (1976) 2.39
The insect endosymbiont Sodalis glossinidius utilizes a type III secretion system for cell invasion. Proc Natl Acad Sci U S A (2001) 2.26
Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol (1992) 2.21
Effectiveness of a mailed reminder on the immunization levels of infants at high risk of failure to complete immunizations. Am J Public Health (1980) 2.16
Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest (1992) 2.12
Binding of host-cell factors to DNA sequences in the long terminal repeat of human T-cell leukemia virus type I: implications for viral gene expression. Proc Natl Acad Sci U S A (1988) 2.12
Nucleotide sequence of the 3' region of an infectious human T-cell leukemia virus type II genome. Proc Natl Acad Sci U S A (1984) 2.10
Breastfeeding reduces risk of respiratory illness in infants. Am J Epidemiol (1998) 2.05
Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol (1995) 2.00
Characterization of the human granulocyte-macrophage colony-stimulating factor promoter region by genetic analysis: correlation with DNase I footprinting. Mol Cell Biol (1988) 1.97
Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. J Neuropathol Exp Neurol (1986) 1.94
Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J Virol (1988) 1.83
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
Molecular basis for familial isolated growth hormone deficiency. Proc Natl Acad Sci U S A (1981) 1.69
HIV and HCMV coinfect brain cells in patients with AIDS. Virology (1988) 1.65
Chemokines and receptors in HIV encephalitis. AIDS (1998) 1.59
Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc Natl Acad Sci U S A (1990) 1.55
Development of a DNA probe for the structural gene of the 2"-O-adenyltransferase aminoglycoside-modifying enzyme. J Infect Dis (1984) 1.54
Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine. J Infect Dis (1997) 1.51
Conservation of Plasmid DNA Sequences in Coronatine-Producing Pathovars of Pseudomonas syringae. Appl Environ Microbiol (1991) 1.51
Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol (1992) 1.51
Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood (2001) 1.50
Hantavirus infection. Adv Intern Med (1997) 1.48
Characterization of serum inhibitors of neutrophil chemotaxis associated with anergy. J Immunol (1974) 1.47
HTLV x-gene product: requirement for the env methionine initiation codon. Science (1985) 1.45
Expression of the 3' terminal region of human T-cell leukemia viruses. Science (1984) 1.44
A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med (1986) 1.44
Intraocular tolerance of perfluorooctylbromide (perflubron) Retina (1995) 1.44
HTLV-1 in acquired adult myopathy. Muscle Nerve (1993) 1.42
Development of two DNA probes for differentiating the structural genes of subclasses I and II of the aminoglycoside-modifying enzyme 3'-aminoglycoside phosphotransferase. Antimicrob Agents Chemother (1985) 1.42
Melioidosis. Forgotten, but not gone! Arch Intern Med (1991) 1.42
HTLV-II transactivation is regulated by the overlapping tax/rex nonstructural genes. Science (1988) 1.41
Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein. J Immunol (2000) 1.39
Storage of cellular 5' mRNA caps in P bodies for viral cap-snatching. Proc Natl Acad Sci U S A (2008) 1.39
THE INCIDENCE OF POST-OPERATIVE CATHETERIZATION IN THE JOHNS HOPKINS HOSPITAL. Ann Surg (1924) 1.39
T-cell-induced expression of human immunodeficiency virus in macrophages. J Virol (1990) 1.38
Genetic analysis of familial isolated growth hormone deficiency type I. J Clin Invest (1982) 1.36
Comparison of sucrose and glucose in the oral electrolyte therapy of cholera and other severe diarrheas. N Engl J Med (1977) 1.35
Egg fluids and cells of the chorioallantoic membrane of embryonated chicken eggs can select different variants of influenza A (H3N2) viruses. Virology (1995) 1.35
Sarcoidosis of the upper respiratory tract and its association with lupus pernio. Thorax (1976) 1.33
Enzyme-linked immunosorbent assay for detection of specific antibodies to Ureaplasma urealyticum serotypes. J Clin Microbiol (1984) 1.33
Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J (1996) 1.32
Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol (2004) 1.26
Nitrogen dioxide and respiratory illnesses in infants. Am Rev Respir Dis (1993) 1.25
Attitude toward hepatitis vaccination among high-risk hospital employees. J Infect Dis (1983) 1.25
The pathophysiology of otitic hydrocephalus. J Laryngol Otol (1997) 1.25
Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest (1993) 1.25
Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB J (1998) 1.23
Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein. Biochem Biophys Res Commun (1988) 1.23
Multiple fibroblast growth factors support growth of the ureteric bud but have different effects on branching morphogenesis. Mech Dev (2001) 1.22
Mechanisms of immune activation of human immunodeficiency virus in monocytes/macrophages. J Virol (1993) 1.22
Different effects of raised [K+]o on membrane potential and contraction in mouse fast- and slow-twitch muscle. Am J Physiol (1997) 1.21
Alcoholism, infection and altered host defenses: a review of clinical and experimental observations. J Chronic Dis (1976) 1.21
Studies of intestinal slow wave activity with a double sucrose gap apparatus. Life Sci I (1971) 1.21
Role of opportunistic viral infections in AIDS. AIDS (1990) 1.19
Brain viral burden in HIV infection. J Neuropathol Exp Neurol (1994) 1.18
Pneumonia treated with imipenem/cilastatin. Am J Med (1985) 1.18
Transforming growth factor-beta and suppression of humoral immune responses in HIV infection. J Clin Invest (1991) 1.18
Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis. AIDS Res Hum Retroviruses (1996) 1.18
Mixed bacterial infection of the pericardium. South Med J (1983) 1.15
IL-6 production by human T lymphocytes. Expression in HTLV-1-infected but not in normal T cells. J Immunol (1991) 1.14
Infection with HTLV-I and HTLV-II: evolving concepts. Semin Hematol (1988) 1.14
Cultured human brain capillary endothelial cells are permissive for infection by human cytomegalovirus. Virology (1990) 1.13
Regulated plasmalemmal expansion in nerve growth cones. J Cell Biol (1991) 1.13
Delayed hypersensitivity skin testing. II. Clinical correlates and anergy. J Infect Dis (1974) 1.10
Comparison of three DNA hybridization methods for detection of the aminoglycoside 2"-O-adenylyltransferase gene in clinical bacterial isolates. Antimicrob Agents Chemother (1985) 1.09
The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indexes of human immunodeficiency virus infection. Arch Neurol (1994) 1.09
Nutritional status: a determinant of severity of diarrhea in patients with cholera. J Infect Dis (1976) 1.08
Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) (2002) 1.08
Delayed hypersensitivity skin testing. I. Response rates in a hospitalized population. J Infect Dis (1974) 1.08
Cosegregation of the renin allele of the spontaneously hypertensive rat with an increase in blood pressure. J Clin Invest (1990) 1.08
Axonal origin and purity of growth cones isolated from fetal rat brain. Brain Res Dev Brain Res (1996) 1.07
Encephalitis caused by human immunodeficiency virus: CT and MR imaging manifestations with clinical and pathologic correlation. Radiology (1990) 1.07
Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center. J Clin Invest (1996) 1.07
Synthesis and anti-HIV activity of 1,1'-dideoxygossypol and related compounds. J Med Chem (1995) 1.06
HTLV-I-associated myelopathy: clinicopathologic correlation with localization of provirus to spinal cord. Neurology (1991) 1.06
Establishment of human T-cell leukemia virus type I T-cell lymphomas in severe combined immunodeficient mice. Blood (1993) 1.06
Tyramide signal amplification method in multiple-label immunofluorescence confocal microscopy. Methods (1999) 1.05
Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis. Am J Pathol (2000) 1.05
Pulsed Doppler duplex sonography and CT of portal vein thrombosis. AJR Am J Roentgenol (1985) 1.04
Anergy in patients with leukocytosis. Am J Med (1974) 1.04
Bacterial meningitis in the absence of CSF pleocytosis. Arch Intern Med (1981) 1.04
Vascular defense responses in rice: peroxidase accumulation in xylem parenchyma cells and xylem wall thickening. Mol Plant Microbe Interact (2001) 1.03
In vitro mutagenesis of the human T-cell leukemia virus types I and II tax genes. J Virol (1989) 1.03